文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

A commentary on 'Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study'.

作者信息

Rui Chunhua, Piao Longhuan, Wang Peng

机构信息

Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University.

Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai Medical College, Fudan University.

出版信息

Int J Surg. 2025 Jan 1;111(1):1648-1649. doi: 10.1097/JS9.0000000000001223.


DOI:10.1097/JS9.0000000000001223
PMID:38377069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11745753/
Abstract
摘要

相似文献

[1]
A commentary on 'Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study'.

Int J Surg. 2025-1-1

[2]
A commentary on 'Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study'.

Int J Surg. 2024-4-1

[3]
A commentary on 'Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study'.

Int J Surg. 2024-2-1

[4]
Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study.

Int J Surg. 2024-2-1

[5]
Letter to the editor: Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study.

Int J Surg. 2024-7-1

[6]
Transarterial Chemoembolization (TACE) Combined with Lenvatinib versus TACE Alone in Intermediate-Stage Hepatocellular Carcinoma Patients Beyond Up-To-Seven Criteria: A Retrospective, Propensity Score-Matched Analysis.

Acad Radiol. 2024-11

[7]
DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.

Cancer Imaging. 2017-2-6

[8]
Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.

Trials. 2012-8-23

[9]
Neutrophil-lymphocyte ratio predicts the therapeutic benefit of neoadjuvant transarterial chemoembolization in patients with resectable hepatocellular carcinoma.

Eur J Gastroenterol Hepatol. 2020-9

[10]
Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.

Med Oncol. 2015-3

本文引用的文献

[1]
Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study.

Int J Surg. 2024-2-1

[2]
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study.

Liver Cancer. 2023-2-7

[3]
Current status and prospect of treatments for recurrent hepatocellular carcinoma.

World J Hepatol. 2023-2-27

[4]
Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma.

World J Gastrointest Oncol. 2023-1-15

[5]
Effect of prophylactic TACE on 5-year survival of patients with hepatocellular carcinoma after hepatectomy.

Oncol Lett. 2019-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索